Current filters:


Popular Filters

8376 to 8400 of 8841 results

Orphan drugs cost likely to be sustainable to European health budgets in the next 10 years, new research shows


Despite an increase in the number of approved orphan drugs in Europe, the overall growth in cost of these…

EuropeMarkets & MarketingPharmaceuticalPricingRare diseases

Extensive consolidation in pharma distribution confined to the retail industry in Russia


In recent years consolidation on the Russian pharmaceutical distribution market has taken place mostly…

EuropeMarkets & MarketingMergers & AcquisitionsPharmaceutical

Whistleblower complaint alleges Rx drugmakers underpaid US Medicaid rebates


According to a multi-count whistleblower action in the USA, alleging violations of federal and state…

LegalMarkets & MarketingNorth AmericaPharmaceutical

Better access to drugs for rare disease patients promised by UK Health Secretary


UK Health Secretary Andrew Lansley this week announced help for patients with rare diseases, whose doctors…

EuropePharmaceuticalRare diseasesRegulation

UNAIDS calls for urgent analysis and more research on hormonal contraceptives and HIV infection risk


The Joint United Nations Programme on HIV/AIDS (UNAIDS) is following with concern data from recent studies…


US biotech sector besieged by debt worries, political dysfunction in 3rd-qtr, says Burrill


The fight in the USA over the raising of the debt ceiling and the debt crisis in Europe have fueled turmoil…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaRegulation

Govt officials and regulators in India consult on stopping spurious drugs


A national consultation meeting was held in India this week to build consensus on the methodology needed…


Bayer celebrates 100 years in Japan, planning continued growth there despite difficult conditions


Germany’s pharma, and material and crop sciences group Bayer (BAY: DE) says it plans to expand its…


Brain disorder bill hits 800 billion euros as Europe faces “ticking bomb,” warns EBC study


The annual cost of brain disorders in Europe has soared to 798 billion euros ($1,070 billion) in what…


Worldwide pharma contract sales revenues to reach $5.24 billion in 2015, says Visiongain


Worldwide pharmaceutical contract sales revenues will reach $5.24 billion in 2015, according to a new…

GlobalMarkets & MarketingPharmaceutical

Malignant melanoma drug market to grow more than seven-fold to $1.5 billion in 2020


The market for malignant melanoma drugs is forecast to expand more than seven-fold over the next decade,…

dabrafenibGlobalMarkets & MarketingOncologyPharmaceuticaltrametinibYervoyZelboraf

AstraZeneca’s Brilique first to be assessed under Germany’s AMNOG, getting positive view


The German reimbursement body, the Federal Joint Committee (G-BA), has published the Institute for Quality…


Hikma enters Moroccan market via $111 million controlling stake in Promopharm


Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe…

GenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalPromopharmRest of the World

Daiichi Sankyo extends reach in Italy, with Ranbaxy to market its products


The Italian subsidiaries of Japanese drug major Daiichi Sankyo (TYO: 4568) and its majority-owned India-based…

Cardio-vascularDaiichi SankyoEuropeGenericsMarkets & MarketingRanbaxy Laboratories

Access to essential HIV/AIDS treatments shows political will as most important factor for success


Access to antiretroviral therapy (ART) has increased dramatically over the last 10 years, according to…

Anti-viralsGlobalMarkets & MarketingPharmaceuticalPolitics

Pharma’s “ill-considered” use of R&D resources in search for Alzheimer's therapeutics reviewed by NeuroPerspective


A comprehensive review of Alzheimer's therapeutics, and a critical assessment of the pharmaceutical industry's…


Another Fosamax trial success for Merck & Co


US drugs giant Merck & Co (NYSE: MRK) says that a federal court jury in New York found in its favor in…

Anti-Arthritics/RheumaticsFosamaxLegalMerck & CoNorth AmericaPharmaceutical

US Senators Grassley and Kohl urge action on Sunshine Law regarding industry relations with physicians


US Senators Chuck Grassley (Republican, Iowa) and Herb Kohl (Democrat, Wisconsin) are pressing the Centers…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Phytopharm gets TSB grant to support development of Myogane in glaucoma


UK-based Phytopharm (LSE: PYM) has been awarded a grant by the Technology Strategy Board to provide funding…


Contract research firm PPD to go private in $3.9 billion acquisition


USA-based contact research organization Pharmaceutical Product Development (Nasdaq: PPDI) says it has…

BiotechnologyMergers & AcquisitionsPharmaceuticalPPD

AstraZeneca unit in-licenses Pfizer drug candidate tremelimumab


Anglo-Swedish drug major AstraZeneca’s (LSE: AZN) US biologics subsidiary MedImmune has in-licensed…


8376 to 8400 of 8841 results

Back to top